Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes General Counsel gave up 2,440 shares (to pay taxes)
  6. 4 Shares withheld for taxes President and CEO gave up 12,547 shares (to pay taxes)
  7. 4 Open-market buy Director bought 7,894,737 shares at $0.76 ($6,000,000)
  8. 4 Open-market buy Chief Financial Officer bought 15,000 shares at $0.59 ($8,850)
  9. 4 Open-market buy General Counsel bought 15,000 shares at $0.60 ($9,000)
  10. 4 Open-market buy Director bought 40,000 shares at $0.57 ($22,640)
  11. 4 Open-market buy President and CEO bought 40,000 shares at $0.60 ($24,000)
  12. 4 Open-market buy Chief Financial Officer bought 10,500 shares at $0.89 ($9,345)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy President and CEO bought 10,000 shares at $1.05 ($10,500)

Page 2 of 36 · 718 filings